Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ t-cell responses

Memorias do Instituto Oswaldo Cruz

Volumn 110, Issue 8, 2015, Pages 1010-1016

  Santana, Vinicius Canato ^a,b   Almeida, Rafael Ribeiro ^a,b   Ribeiro, Susan Pereira ^a,b   Ferreira, Luís Carlos De Souza ^a   Kalil, Jorge ^a,b   Rosa, Daniela Santoro ^b,c   Cunha Neto, Edecio ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia iii INCT   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DNA vaccine; Granulocyte macrophage colony stimulating factor; HIV; Polyfunctional CD4+ T cells

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; PROTEIN BINDING; TUMOR NECROSIS FACTOR; VIRUS ANTIGEN;

ANIMAL; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CELL MOTION; CELLULAR IMMUNITY; CONSERVED SEQUENCE; DRUG EFFECTS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GENE VECTOR; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PLASMID;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CONSERVED SEQUENCE; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE, INBRED BALB C; PLASMIDS; PROTEIN BINDING; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, DNA;

EID: 84949666305     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-02760150283     Document Type: Article

References (35)

1. Ahlers JD, Belyakov IM, Terabe M, Koka R, Donaldson DD, Thomas EK, Berzofsky JA 2002. A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L. Proc Natl Acad Sci USA 99: 13020-13025.
2. Arens R, Schoenberger SP 2010. Plasticity in programming of effec- tor and memory CD8 T-cell formation. Immunol Rev 235: 190-205.
3. Barouch DH, Santra S, Tenner-Racz K, Racz P, Kuroda MJ, Schmitz JE, Jackson SS, Lifton MA, Freed DC, Perry HC, Davies ME, Shiver JW, Letvin NL 2002. Potent CD4(+) T-cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J Immunol 168: 562-568.
4. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, Roederer M, Seder RA 2007. Multifunctional Th1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843-850.
5. Diniz MO, Lasaro MO, Ertl HC, Ferreira LCS 2010. Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein D. Clin Vaccine Immunol 17: 1576-1583.
6. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Oka- moto Y, Casazza JP, Kuruppu J, Kuntsman K, Wolinsky S, Grossman Z, Dybul M, Oxenius A, Price DA, Connors M, Koup RA 2002. HIV preferentially infects HIV-specific CD4(+) Tcells. Nature 417: 95-98.
7. Ferre AL, Hunt PW, McConnell DH, Morris MM, Garcia JC, Pol- lard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL 2010. HIV Controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4(+) T-cell responses. J Virol 84: 11020-11029.
8. Fonseca SG, Coutinho-Silva A, Fonseca LAM, Segurado AC, Moraes SL, Rodrigues H, Hammer J, Kallas EG, Sidney J, Sette A, Kalil J, Cunha-Neto E 2006. Identification of novel consensus CD4 T- cell epitopes from clade B HIV-1 whole genome that are frequent- ly recognized by HIV-1 infected patients. AIDS 20: 2263-2273.
9. Gloster SE, Newton P, Cornforth D, Lifson JD, Williams I, Shaw GM, Borrow P 2004. Association of strong virus-specific CD4 T-cell responses with efficient natural control of primary HIV-1 infection. AIDS 18: 749-755.
10. Haddad D, Ramprakash J, Sedegah M, Charoenvit Y, Baumgartner R, Kumar S, Hoffman SL, Weiss WR 2000. Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor at- tracts infiltrates including immature dendritic cells into injected muscles. J Immunol 165: 3772-3781.
11. Kutzler MA, Weiner DB 2008. DNA vaccines: ready for prime time? Nat Rev Genet 9: 776-788.
12. Lai L, Kwa S, Kozlowski PA, Montefiori DC, Ferrari G, Johnson WE, Hirsch V, Villinger F, Chennareddi L, Earl PL, Moss B, Amara RR, Robinson HL 2011. Prevention of infection by a granulocytemacrophage colony-stimulating factor co-expressing DNA/modified Vaccinia Ankara simian immunodeficiency virus vaccine. J Infect Dis 204: 164-173.
13. Lindenstrøm T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Sed- er RA, Rosenkrands I, Andersen P 2009. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T-cells. J Immunol 182: 8047-8055.
14. Livingston B, Crimi C, Newman M, Higashimoto Y, Appella E, Sidney J, Sette A 2002. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J Immunol 168: 5499-5506.
15. McKay PF, Barouch DH, Santra S, Sumida SM, Jackson SS, Gor- gone DA, Lifton MA, Letvin NL 2004. Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4(+) and CD8(+) T lymphocyte responses. Eur J Immunol 34: 1011-1020.
16. Nambiar JK, Ryan AA, Kong CU, Britton WJ, Triccas JA 2010. Mod- ulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tubercu- losis infection. Eur J Immunol 40: 153-161.
17. Pahar B, Gray WL, Phelps K, Didier ES, Deharo E, Marx PA, Traina-Dorge VL 2012. Increased cellular immune responses and CD4+T-cell proliferation correlate with reduced plasma vi- ral load in SIV challenged recombinant simian varicella virussimian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaques. Virol J 9: 160.
18. Porichis F, Kaufmann DE 2011. HIV-specific CD4 T-cells and immune control of viral replication. Curr Opin HIV AIDS 6: 174-180.
19. Qiu JT, Chang TC, Lin CT, Chen YM, Li FQ, Soong YK, Lai CH 2007. Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag. Vaccine 25: 253-263.
20. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-2220.
21. Ribeiro SP, Rosa DS, Fonseca SG, Mairena EC, Postol E, Oliveira SC, Guilherme L, Kalil J, Cunha-Neto E 2010. A vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T-cell responses in mice transgenic to multiple common HLA class II molecules. PLoS ONE 5: e11072.
22. Robinson HL, Montefiori DC, Villinger F, Robinson JE, Sharma S, Wyatt LS, Earl PL, McClure HM, Moss B, Amara RR 2006. Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine. Virology 352: 285-294
23. Rodríguez AM, Pascutti MF, Maeto C, Falivene J, Holgado MP, Turk G, Gherardi MM 2012. IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality. PLoS ONE 7: e37801.
24. Rosa DS, Ribeiro SP, Almeida RR, Mairena EC, Postol E, Kalil J, Cunha-Neto E 2011. A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4(+) and CD8(+) T cell responses. PLoS ONE 6: e16921.
25. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD 1997. Vigorous HIV-1-specific CD4(+) T-cell responses associated with control of viremia. Science 278: 1447-1450.
26. Sacha JB, Giraldo-Vela JP, Buechler MB, Martins MA, Maness NJ, Chung C, Wallace LT, Leon EJ, Friedrich TC, Wilson NA, Hiraoka A, Watkins DI 2009. Gag- and Nef-specific CD4(+) T-cells recognize and inhibit SIV replication in infected macrophages early after infection. Proc Natl Acad Sci USA 106: 9791-9796.
27. Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, Ranasinghe S, Lindqvist M, Davis I, Lane K, Rychert J, Rosenberg ES, Piechocka-Trocha A, Brass AL, Brenchley JM, Walker BD, Streeck H 2012. HIV-specific cytolytic CD4 T-cell responses during acute HIV infection predict disease outcome. Sci Transl Med 4: 123ra25.
28. Song RJ, Liu SQ, Adams RJ, Leong KW 2006. Enhancing efficacy of HIV Gag DNA vaccine by local delivery of GM-CSF in murine and macaque models. J Interferon Cytokine Res 26: 380-389.
29. Tenbusch M, Kuate S, Tippler B, Gerlach N, Schimmer S, Dittmer U, Ueberla K 2008. Co-expression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T-cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity. BMC Immunol 9: 13.
30. Vaccari M, Mattapallil J, Song K, Tsai WP, Hryniewicz A, Venzon D, Zanetti M, Reimann KA, Roederer M, Franchini G 2008. Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8(+) T-cells induced by vaccination during CD4(+) T-cell deficiency. J Virol 82: 9629-9638.
31. Watkins DI, Burton DR, Kallas EG, Moore JP, Koff WC 2008. Non- humam primate models and the failure of the Merck HIV-1 vaccine in humans. Nat Med 14: 617-621.
32. Weiss WR, Ishii KJ, Hedstrom RC, Sedegah M, Ichino M, Barnhart K, Klinman DM, Hoffman SL 1998. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol 161: 2325-2332.
33. Xu R, Megati S, Roopchand V, Luckay A, Masood A, Garcia-Hand D, Rosati M, Weiner DB, Felber BK, Pavlakis GN, Sidhu MK, Eldridge JH, Egan MA 2008. Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines. Vaccine 26: 4819-4829.
34. Zhai Y, Zhou Y, Li X, Feng G 2015. Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor. Mol Med Rep 12: 199-209.
35. Zheng N, Fujiwara M, Ueno T, Oka S, Takiguchi M 2009. Strong ability of Nef-specific CD4(+) cytotoxic T-cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4(+) T-cells and macrophages. J Virol 83: 7668-7677